None listed
Conditions
Brief summary
This a randomised controlled trial of a website called Australian Cancer Trials Online. This website provides information about cancer clinical trials in Australia. The trial will look at the effect of the website on clinial trial recruitment and doctor patient communication about cancer clinical trials.
Interventions
The intervention is the Australian Cancer Trials Online website. This will be a website that provides up to date information about the cancer clinical trials currently recruiting patients in Australia. It will contain two decision support tools (a question prompt list and decision aid) and consumer support information which will help consumers make a decision whether to participate in a clinical trial and increase their knowledge and understanding of cancer clinical trials. Medical oncologists a
The intervention is the Australian Cancer Trials Online website. This will be a website that provides up to date information about the cancer clinical trials currently recruiting patients in Australia. It will contain two decision support tools (a question prompt list and decision aid) and consumer support information which will help consumers make a decision whether to participate in a clinical trial and increase their knowledge and understanding of cancer clinical trials. Medical oncologists and patients in the intervention arm will have access to the website. The consultation between each of the participating medical oncologists and their patients will be audio-taped. Each patient will have their consultation audio-taped once. The duration of the intervention is for 6 months.
Sponsors
Dr Rachel Dear
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used)
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
Patients invited to participate in the study must be: 1) Patients starting treatment for the first time. For example: new patients, patients not initially suitable for chemotherapy but are currently suitable due to symptomatic disease or improved performance status. 2) Patients in whom a treatment change is anticipated. For example: in the adjuvant setting a patient with early breast cancer finishing adjuvant chemotherapy and about to start adjuvant endocrine therapy and in the metastatic setting patients with progressive disease needing to change chemotherapy or all lines of chemotherapy utilised. 3) Patients with email and internet access. 4) Patients due to see their medical oncologist in 2 weeks time over a period of 4 to 8 weeks (longer may be necessary).
Exclusion criteria
Medical oncologists working outside NSW and Victoria and medical oncologists who do not have email and internet access. Patients who do not have email and internet access, who are already participating in a clinical trial and do not have command of English.
Outcome results
None listed